Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2004 2
2005 2
2006 2
2007 2
2008 2
2009 1
2010 1
2011 4
2012 1
2013 4
2014 2
2015 5
2016 3
2017 3
2018 4
2019 4
2020 3
2021 2
2023 4
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

49 results

Results by year

Filters applied: . Clear all
Page 1
Targeting cancer-derived extracellular vesicles by combining CD147 inhibition with tissue factor pathway inhibitor for the management of urothelial cancer cells.
Boddu VK, Zamzow P, Kramer MW, Merseburger AS, Gorantla SP, Klinger M, Cramer L, Sauer T, Gemoll T, von Bubnoff N, Gieseler F, Darabi M. Boddu VK, et al. Among authors: gieseler f. Cell Commun Signal. 2024 Feb 15;22(1):129. doi: 10.1186/s12964-024-01508-x. Cell Commun Signal. 2024. PMID: 38360687 Free PMC article.
Contributing and limiting factors to guideline-adherent therapy in senior and elderly breast cancer patients: a questionnaire-based cross-sectional study using clinical and cancer registry data in Germany.
Heidenreich A, Fuchshofen R, Elsner S, Gieseler F, Katalinic A, Hübner J. Heidenreich A, et al. Among authors: gieseler f. J Cancer Res Clin Oncol. 2023 Dec;149(19):17297-17306. doi: 10.1007/s00432-023-05446-y. Epub 2023 Oct 10. J Cancer Res Clin Oncol. 2023. PMID: 37815663 Free PMC article.
Three-month life expectancy as inclusion criterion for clinical trials in advanced pancreatic cancer: is it really a valid tool for patient selection?
Weiss L, Heinemann V, Fischer LE, Gieseler F, Hoehler T, Mayerle J, Quietzsch D, Reinacher-Schick A, Schenk M, Seipelt G, Siveke JT, Stahl M, Vehling-Kaiser U, Waldschmidt DT, Dorman K, Zhang D, Westphalen CB, von Bergwelt-Baildon M, Boeck S, Haas M. Weiss L, et al. Among authors: gieseler f. Clin Transl Oncol. 2024 May;26(5):1268-1272. doi: 10.1007/s12094-023-03323-1. Epub 2023 Oct 4. Clin Transl Oncol. 2024. PMID: 37794220 Free PMC article.
The role of family confidants and caregivers in the care of older cancer patients: Extending the concept of "shared decision-making".
Gieseler F, Heidenreich A, Schubert J, Frielitz F, Rehmann-Sutter C, Wörler F, Schües C, Hübner J, Elsner S, Block K, Rody A, von Bubnoff N, Keck T, Steimann M, Endsin G, Katalinic A. Gieseler F, et al. Health Sci Rep. 2021 May 6;4(2):e281. doi: 10.1002/hsr2.281. eCollection 2021 Jun. Health Sci Rep. 2021. PMID: 33977163 Free PMC article.
Ambrisentan, an endothelin receptor type A-selective antagonist, inhibits cancer cell migration, invasion, and metastasis.
Kappes L, Amer RL, Sommerlatte S, Bashir G, Plattfaut C, Gieseler F, Gemoll T, Busch H, Altahrawi A, Al-Sbiei A, Haneefa SM, Arafat K, Schimke LF, Khawanky NE, Schulze-Forster K, Heidecke H, Kerstein-Staehle A, Marschner G, Pitann S, Ochs HD, Mueller A, Attoub S, Fernandez-Cabezudo MJ, Riemekasten G, Al-Ramadi BK, Cabral-Marques O. Kappes L, et al. Among authors: gieseler f. Sci Rep. 2020 Sep 28;10(1):15931. doi: 10.1038/s41598-020-72960-1. Sci Rep. 2020. PMID: 32985601 Free PMC article.
49 results